EZH2 and breast cancer: It has been reported that decreased expression of BRCA1 triggers genome-wide EZH2 retargeting and elevates H3K27me3 levels which blocks embryonic cell differentiation and enhances breast cancer migration and invasion (Wang et al., 2013).